Steward Partners Investment Advisory »

Arcutis Biotherapeutics shares owned by Steward Partners Investment Advisory

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Steward Partners Investment Advisory from 13F filings

Historical chart of Steward Partners Investment Advisory investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Steward Partners Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Steward Partners Investment Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $646 200 3.23
2021-09-30 $2.0k 100 20.00

More positions owned by Steward Partners Investment Advisory

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
UnitedHealth (UNH)
Ishares Tr Rus 1000 Grw Etf (IWF)
Home Depot (HD)
Tesla Motors (TSLA)

View all positions for Steward Partners Investment Advisory

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Vanguard Group
Franklin Resources
Millennium Management
Opaleye Management
Jennifer Ranahan
Deutsche Bank Aktiengesellschaft
Tejara Capital
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Federated Investors
AMI Asset Management Corporation
Walleye Trading Advisors

View all funds holding Arcutis Biotherapeutics